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Abstract. The accumulation of two myogenic regula-
tory proteins, MyoD and myogenin, was investigated
by double-immunocytochemistry and correlated with
myosin heavy chain expression in different classes of
myoblasts in culture and during early myogenesis in
vivo.
During in vitro differentiation of fetal myoblasts,
MyoD-positive cells were detected first, followed by
the appearance of cells positive for both MyoD and
myogenin and finally by the appearance of differen-
tiated myocytes and myotubes expressing myosin heavy
chain (MHC) . A similar pattern of expression was ob-
served in cultures of embryonic and satellite cells. In
contrast, most myogenic cells isolated from newly
formed somites, expressed MHC in the absence of de-
tectable levels of myogenin or MyoD.
In vivo, the appearance of both myogenin and MyoD
proteins was only detected at 10.5 d postcoitum (d.p.c.),
when terminally differentiated muscle cells could al-
ready be identified in the myotome. Parasagittal sec-
tions of the caudal myotomes of 10.5-d-old embryos
showed that expression of contractile proteins preceded
the expression of myogenin or MyoD and, when co-
//~//\
DFFERENT populations of skeletal myoblasts (embry-
onic, fetal, adult, fast, slow, and mixed) might ac-
countin part for theasynchronous generation and the
phenotypic heterogeneity of muscle fibers (Stockdale and
Miller, 1987; Cossu and Molinaro, 1987; Stockdale, 1989; Vi-
varelli et al., 1988). Until now, however, it has not been clear
how such myoblast heterogeneity might arise and whether it
might be in any way relevant to the later phases of muscle
development.
Dr. G. Lyons'presentaddress is DepartmentofAnatomy, University ofWis-
consin, Madison, Wl.
1. Abbreviations used in this paper: HLH, helix-loop-helix; rt, room tem-
perature.
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expressed, MHC and myogenin did not co-localize
within all the cells of the myotome. In the limb bud,
however, many myogenin (or MyoD) positive/MHC
negative cells could be observed in the proximal re-
gion at day 11. During further embryonic development
the expression of these proteins remained constant in
all the muscle anlagens examined, decreasing to a low
level during the late fetal period. Western and North-
ern analysis confirmed that the myogenin protein could
only be detected after 10.5 d .p.c. while the corre-
sponding message was clearly present at 9.5 d.p.c.,
strongly suggesting a posttranscriptional regulation of
myogenin during this stage of embryonic development.
These data show that the first myogenic cells which
appear in the mouse myotome, and can be cultured
from it, accumulate muscle structural proteins in their
cytoplasm without expressing detectable levels of myo-
genin protein (although the message is clearly accumu-
lated). Neither MyoD message or protein are detect-
able in these cells, which may represent a distinct
myogenic population whose role in development re-
mains to be established.
The recent identification of four myogenic regulatory
genes (MyoD, myogenin, myf-5, and myf-6/MRF4/hercu-
lin), belonging to the helix-loop-helix (HLH)' family of
DNA binding proteins and capable of activating myogenesis
upon transfection in non-muscle cells (reviewed in Olson,
1990; Weintraub, 1991), has opened new approaches to the
problem of myogenic cell heterogeneity. In fact, the differen-
tial expression of one or more of these genes in different
populations of myoblasts might be responsible for subtle
phenotypic differences observed amongthese different myo-
genic cells. In situ hybridization studies on the expressionof
these factors during mouse embryonic development support
this hypothesis, since each of the myogenic factors shows a
unique pattern of expression in space and time. Myf-5 is the
first of these genes to be detected in the dorsal lip of the der-
1243mamyotome at eight days of development, but this expres-
sion disappears at about 12-13d (Ott et al., 1991). Myogenin
and MyoD transcripts appear, respectively, at 8.5 and 10.5 d
in the myotome and at -11 d in the limb bud and continue
to be expressed (Sassoon etal ., 1989). Finally, myf-6 is tran-
siently expressed in the myotome but not in the limb buds
during the embryonic period and is subsequently expressed
in all muscle during fetal and adult life (Bober et al., 1991;
Hinterberger et al., 1991) .
The recent availability of polyclonal antibodies and mAbs
against the protein products of several of these genes allows
an immunohistochemical analysis of the expression of these
factors. Here we describe the expression of two of these fac-
tors, MyoD and myogenin, in different classes of myoblasts
in vitro and in vivo.
Materials and Methods
Cell Cultures
Cells were cultured from somites or limbs of mouse embryos and fetuses,
ranging in age from 8 to 17 d postcoitum (d.p.c.), and from limbs of adult
mice as previously described (Vivarelli and Cossu, 1986; Cossu et al.,
1983). Briefly, embryonic tissue was dissociated by gentle pipetting ina Ca-
Mg-free PBS, while fetaland adult tissues were digested with 0.05% trypsin
(Difco Laboratories Inc., Detroit, MI) in PBS fordifferent periods at 37°C.
After the proteolytic digestion, the tissues were fragmented by repeated
pipetting, the debris was removed by filtration through sterile nylon gauze,
and the cells were collected by centrifugation. Unless otherwise specified,
cells were inoculated at an initial cell density of 3 x 105 cells/ml in DME
(Flow Laboratories, Irvine, Scotland) supplemented with 15 % horse serum
(Flow Laboratories) and 3 % chick embryo extract.
Immunocytochemistry
The following antibodies were used in this study: (a) An anti-MyoD rabbit
antiserum (obtained from H. Weintraub; Tapscott et al., 1988). (b) Anti-
myogenin mAbs, obtained by immunizing mice with rat recombinant myo-
genin (Wright et al., 1991). The monoclonal F5D reacts in ELISA with
recombinant myogenin but not with MyoD, Myf 5, or MRF4. The epitope
is locatedjust carboxyterminalto the HLH domain ofthe myogenin protein.
On Western blots the antibody reacts with a pair of ti34-kD polypeptides
present in myogenic but not in fibroblastic cell lines. The reaction is abol-
ished by pre-incubating the antibody with recombinant myogenin. Other
monoclonals (D12F, A3B), directed against different myogenin epitopes,
werealso used whereindicated. (c) MHC antibodies. MF20 is amAb which
recognizes all sarcomeric myosins (provided by D. A. Fischman; Bader et
al., 1982). A rabbit antiserum against (MHC) was obtained from Sigma
Chemical Co. (St. Louis, MO) . In control experiments ontissue culture and
cryostatsections, it stained the samecells and subcellularstructures stained
by MF20, i.e., sarcomeres in skeletal and cardiac muscle cells.
Embryos werefixed in 4% paraformaldehydein PBS, dehydratedthrough
a series of sucrose solutions (12, 18, and 30%), sectioned on a cryostat, and
mounted on gelatin-coated slides. The slides were washed in 1% BSA in
PBS for 30 min. Sections werepretreated withgoat anti-mouse IgG (Cappel
Laboratories, Malvern, PA) at 1:30 dilution to reduce nonspecific fluores-
cence.
Thetissue sections and culturedcells were incubated for 1 h at room tem-
perature (rt) with polyclonal antibodies (at dilutions ranging from 1:50 to
1:500) and mAbs (diluted 1:10); after the incubation, the samples were
washed three times in 1% BSA in PBS and then incubated with a fluores-
cein-conjugated goat anti-rabbit Ig and with a rhodamine-conjugated goat
anti-mouse Ig (both second antibodies were obtained from Cappel Labora-
tories and used at 1:30 dilution for 1 h at rt) . Cultures and slides were
mounted in PBS at pH 8, supplemented with 75% glycerol, and observed
under an epifluorescence microscope (Carl Zeiss, Oberkochen, Germany).
Western BlotAnalysis
Tissues were homogenized in 0.4 M NaCl, 50 mM Tris-Cl, pH 7.4, 5 mM
MgC12, and 1 mM each of the protease inhibitors benzamidine, PMSF,
leupeptin, and soybean trypsin inhibitor (all from Sigma Chemical Co.).
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The homogenate was centrifuged at 100,000 gandthe supernatant was sepa-
rated on a 10% SDS-PAGE, transferred to nitrocellulose, and incubated
withanti-myogenin antibodies at 1:10 or 1:50 dilution for 2 h at rt. The reac-
tion was revealedby the immunogold-silver staining kit (Amersham Corp.,
Arlington Heights, IL) using an auroprobe BLplus goat anti-mouse second
antibody according to manufacturer's instructions. Under identical con-
ditions 1-2 ng of recombinant myogenin (Wright et al., 1991) could be
detected.
Northern BlotAnalysis
Total RNA was prepared from somites of9.5- or 11.5-d-old mouse embryos
or from differentiating C2C12 cells by acid phenol extraction (Chomc-
zynsky and Sacchi, 1987) . Gel electrophoresis, RNA transfer, and hybrid-
ization conditions have previously been described (Bober et al., 1991). The
probes usedfor Northern blot analysis were a DNA fragment corresponding
to the 3' UTR ofthe myogenin cDNA (as described for cRNA probes used
for in situ hybridization) and the pAl plasmid which recognizes 0-actin
(Ferrari et al., 1990) . DNA was labeled to a specific activity of 1-3 x 108
cpm/,ug using the multiprime labeling kit from Amersham.
Preparation andPre-hybridization ofTflssueSections
CDI mouse embryos were fixed and embedded as described for immunocy-
tochemistry. Restriction fragments, which specifically detect myogenin
transcripts, were subcloned in the Bluescript transcription vector (Strata-
gene, La Jolla, CA) and grown in Escherichia coli TGI. The probe corre-
sponds to the 3' terminal 700 by ofthe rat myogenin cDNA (Wright et al.,
1989). The cRNA transcripts were synthesized according to the manufac-
turers instructions and labeled with 35S-UTP (>1,000 Ci/mmole; Amer-
sham Corp.). cRNA transcripts were partially hydrolyzed to a mean size
of 70 nucleotides for efficient access to in situ mRNA.
Hybridization and WashingProcedures
Hybridization and washing procedures were performed as described in
Lyons et al. (1990). Slides were dipped in undiluted NTB-2 nuclear track
emulsion (Eastman Kodak Co., Rochester, NY) and exposed for 1 wk at
4°C. Slides were developed in Kodak D-19 and analyzed using light and
dark field optics on an Axioplan microscope (Carl Zeiss).
Nomenclature
Throughout this paper, the following nomenclature (as described in Stock-
dale and Miller, 1987) will be adopted: (a) Myoblasts are myogenic,
mononucleated, mitotic cells that are considered "committed" to the myo-
genic lineage but do not express skeletal muscle MHC in their cytoplasm.
(b) Myotubes are postmitotic, oligo (>2), or multinucleated cells that ex-
press different MHC proteins in their cytoplasm. (c) Myocytes are postmi-
totic mononucleated cells that express different MHC proteins in their
cytoplasm. (d) The embryonic period ofdevelopment, in which major mor-
phogenetic events take place in the developing organism, lasts from gastru-
lation (6.5 d.p.c.) to 12 d.p.c. in the mouse. (e) The fetal period, corre-
sponding to a period of growth in the already formed organism, lasts from
day 13 to birth. (f) Embryonic myoblasts are isolated from muscle anlagens
of mouse embryos ranging in age from 10 to 12 d.p.c. and correspond to
embryonic myoblasts isolated from chick E5 stage (Stockdale and Miller,
1987) and to early muscle colony-forming myoblasts (Rutz and Hauschka,
1982): they form oligonucleated myotubes (hence, referred to as embryonic
myotubes) which co-express fast embryonic and slow MHC and differenti-
ate in the presence ofTPA (Cossu et al., 1988). (g) Fetal myoblasts are iso-
lated from fetal musclesofmouse fetuses rangingin age from 15 to 17 d.p.c.
and correspond to fetal myoblasts isolated from chick day 12 embryos and
to late muscle colony-forming myoblasts: they form large multinucleated
myotubes (fetal myotubes) that initially express only fast embryonic MHC.
Results
In Vitro Studies
Fetal myoblasts, isolated from limb muscles of 16 d.p.c.
mouse fetuses, were fixed after different days in culture and
incubated with different combinations of antibodies directed
against MyoD, myogenin, or MHC. Fig. 1 shows fetal myo-
1244blasts double stained with MF20 (which stains all sarco-
meric myosins) versus an anti-MyoD polyclonal antibody. At
day 1 of culture (Fig . 1, A and B), many nuclei stained with
the anti-MyoD antibody (Fig. 1 B) while very few cells
stained with MF20 (an example is shown in Fig . 1 A) . At
the onset of fusion (day 3 of culture) many differentiated
myocytes and newly formed myotubes stained with both the
anti-MyoD and MF20 antibodies, while many cells stained
with anti-MyoD but not with MF20 (Fig . 1, C and D) . No
MF20+/MyoD- cells could be detected . After fusion was
completed (day 5 of culture), the majority of cells stained
with both antibodies (Fig. 1, E and F) but the intensity of
staining in myotube nuclei had decreased . The same culture
was also double stained withF5D (amcab specific for myo-
genin) and anti-MyoD antibody. At day 1 of culture (Fig . 2,
A andB)many more cells stained with anti-MyoD than with
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Figure 1. Double immunofluo-
rescence of fetal myoblasts
cultured from 16-d.p.c. mouse
fetal limbs . The cells were
stained with MF20 mcab (A,
C, and E) and anti-MyoD
pcab (B, D, and F) at day 1 (A
and B), day 3 (C and D), and
day 5 (E and F) of culture.
Arrowhead shows a nucleus
stained with anti-MyoD anti-
body, whose fluorescence was
considered threshold in order
to quantify positive cells (see
Fig . 3) . Bar, 10 ,um .
anti-myogenin ; at day 3, however (Figs . 2, C and D), the two
proteins co-localized in virtually all of the myogenic cells,
as they did in the nuclei of myotubes at day 5 (Fig. 2, E and
F) even though, at this stage, fluorescence was weaker in
some nuclei . Fig . 3 illustrates the increase in the number of
MyoD, myogenin, andMHC positive cells in cultures of fetal
myoblasts . When the experiment was repeated on satellite
cells, isolated from skeletal muscle ofadult mice, essentially
the same results were obtained (data not shown) .
Embryonic myoblasts, isolated from 11-d.p.c. limb buds,
showed a somewhat different pattern of expression ofMyoD
and myogenin in vitro . On day 1 of culture, many myogenic
cells expressed MyoD and myogenin in their nuclei while
still negative for the presence of MHC in their cytoplasm .
Unexpectedly a minor, but reproducible, fraction ofthe myo-
genic population expressedMHC in the cytoplasm but no de-
1245tectable amount of MyoD or myogenin in their nuclei . Fig .
4 shows examples of these myocytes, (MHC+/MyoD- in
Fig . 4, A, B, and MHC+lntyogenin- in C and D) together
with MHC-/MyoD+ or myogenin+ myoblasts and MHC+/
MyoD+ or myogenin+ embryonic myotubes. The presence
of MHC+-differentiated muscle cells which do not express
detectable levels ofMyoD or myogenin in their nuclei might
depend on transient expression ofthese gene products in em-
bryonic myogenic cells or on the existence of a subpopula-
tion of cells which can differentiate without ever expressing
these proteins (at levels detectable by immunofluorescence) .
To discriminate between these two possibilities, we analyzed
early myoblasts from somites for the expression ofMyoD and
myogenin during in vitro differentiation . In fact, ifMyoD-/
myogenin- myoblasts represent a different population, it is
conceivable that this population might be an early one (since
it is not apparently present among fetal cells) and therefore
would predominate at the earliest stages of myogenesis . If,
on the other hand, transient expression ofMyoD and myoge-
nin was a feature of all embryonic myoblasts, one would ex-
pect to find MyoD-/myogenin--differentiated cells in simi-
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Figure 2 . Double immunofluorescence
of fetal myoblasts cultured from 16-
d.p.c. mouse fetal limbs . The cultures
were stained with anti-MyoD pcab (A,
C, and E) and F5D (anti-myogenin)
mcab (B, D, and F) at day 1 (A and
B), day 3 (C and D), and day 5 (E
and F) in vitro . Arrows show myo-
blasts whose nuclei expressMyoD but
not myogenin . Bar, 10 /Am .
lar proportions among somitic myoblasts. When myoblasts
were explanted from somites of 8.5 d.p.c. mouse embryos
and grown in culture, many mononucleated, cross-striated,
differentiated (MHC-positive) myocytes appeared during the
first days in vitro (Fig . 5, A andB) . None of these myocytes
(out of 565 myocytes scored in three separate cultures) ex-
pressed detectable levels of MyoD or myogenin in their
nuclei during the first day of culture. After 2 d in culture,
several MyoD and myogenin positive cells appeared but none
of these cells yet expressed MHC (Fig . 5, C and D) . Fig . 6
illustrates the increase in the number of MyoD, myogenin,
and MHC positive cells in micromass cultures where an ini-
tial inoculum of 10 5 somitic and neural tube-derived cells
were plated : only MHC positive (MyoD-/myogenin-) cells
increase in number during the first day of somitic cultures,
while myogenin+ (or MyoD+) cells begin to accumulate
during the second and third day in vitro . Thus this pattern
is radically different from that observed in cultures of fetal
myoblasts, where only MHC- (MyoD+/myogenin+) cells
increase in number during the first days in vitro (Fig . 3) . It


















Figure 3. Time course of appearance of cells positive for MyoD
(--A -) myogenin ( . . .a .. .) or MHC (---0---)/microscopic field
(scored at 400x), during culture of fetal myoblasts. (-----r----):
total nuclei/microscopic field. 105 cells were plated in 30-mm
dishes in 1.5 ntl of complete medium, fixed at daily intervals,
stained with the different antibodies, and the number of positive
nuclei (for MyoD)and cells (for MHC) was counted. Since fluores-
cence varied from cell to cell, we considered positive those nuclei
whose fluorescence could be distinguished over cytoplasmic back-
ground (an example of such nuclei is show in Fig. 1 B) . When
myotubes appeared, each nucleus within the myotube was counted
as a separate cell. On day 5 of culture, -50-70% of nuclei were
in myotubes.
fraction (<5 %) of the total cell population, since the great
majority ofcells, cultured from these early stages, do not ex-
press any marker which might allow immunocytochemical
identification. When the experiment was repeated with 9.5-
d.p.c. embryos, the results were similar, except that MyoD+/
myogenin+ myoblasts appeared after the first day of culture
and in larger numbers, suggesting that their appearance is
somehow timed in the embryo at -10 d.p.c. (see below) . To
investigate whether these MyoD-/myogenin- myogenic
cells might give rise to MyoD+/myogenin+ myoblasts we
cloned cells isolated from 9.5-d.p.c. somites. After 7 d of
clonal culture, the dishes were similarly stained with the var-
ious combinations of antibodies. Fig. 7 shows examples of
these cells, the majority of which appeared as single, non-
clonogenic differentiated MHC+ myocytes. Approximately
60% of these single myocytes were myogenin+, the others
myogenin- (Fig. 7, A and B). No MHC-/myogenin+ cells
were observed. A minority of small (2-8 nuclei) differen-
tiated MHC+ clones were observed: in 22 of these clones,
all the nuclei were myogenin+ . Other 5 MHC+ differen-
tiated clones were composed of two nuclei which were
myogenin- (one of these clones is shown in Fig. 7, E and
F). The results of three separate experiments are reported
in Table I. In no case were myogenin+ and myogenin- cells
present in the same clone.
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In Vivo Studies
To investigate when and where these "primordial" (MHC+/
MyoD-/myogenin-) muscle cells might appear during em-
bryonic development in vivo, we incubated serial sections
(both transverse and parasagittal) of mouse embryos, rang-
ing in age from 8.5 to 13 d .p.c., with the same combinations
of antibodies used for the in vitro study. Fig. 8 shows a dou-
ble immunofluorescence of9.5 (A and B) and 10.5 d.p.c. (C
and D) embryos incubated with both anti-MyoD (A and C)
and anti-myogenin (B and D) antibodies. It is clear from the
figure that no nuclei can be labeled by either antibody in a
transverse section of 9.5-d.p.c. embryos (which shows the
neural tube with adjacent somites), while many myotomal
nuclei were labeled by both antibodies at 10.5 d.p.c. In more
than 50 different sections through many different 8.5- to 9.5-
d.p.c. embryos (ranging from 5 to 30 somites) we never de-
tected any nucleus positive for either MyoD or myogenin.
Once fluorescence became detectable in myotomes at 10
d.p.c. (>40 somites), the great majority of nuclei co-ex-
pressed both MyoD and myogenin. Similarly, the majority
ofthe cellspresent in theproximal region ofthe forelimb bud
at 11.5 d.p.c., co-expressed MyoD and myogenin (Fig. 8, E
and F). Since this is the developmental period when termi-
nally differentiated muscle cells appear in the myotomes
(Furst et al., 1989; Babai et al., 1990), we compared the ap-
pearance of MHC with that of both the MyoD and myogenin
proteins. To this purpose, we incubated transverse and para-
sagittal sections of 10.5-d.p.c. embryos with the various anti-
bodies. By taking advantage of the cranio-caudal gradient of
muscle differentiation, we couldobserve both MHC positive
and negative somites in a cranao-caudal succession through
the same section. Fig. 9 (A and B) shows an example of two
adjacent MHC+/myogenin+ somites, where positive nuclei
are usually located in the central area ofthe myotome, whose
edges are characterized by elongated MHC+/myogenin-
cells. Fig. 9 (C and D) shows a more caudal region of the
embryo, where the cranial somite appears to co-express
MHC and myogenin, while the next caudal somite is exclu-
sively composed ofMHC+/myogenin- cells. In a transverse
section, MHC+ cells are observed throughoutthe myotome
but myogenin+ nuclei appear only in a proportion of these
cells (Fig. 9, E and F). Identical results were obtained co-
staining parallel sections with anti-MyoD and anti-MHC
(data not shown). At 11 d.p.c., all the myotomes expressed
MyoD, myogenin, and MHC. Infrequently, small areas in the
lateral edge ofthe myotome did not express detectable levels
of myogenin (an example is shown in Fig. 10, A and B). In
the developing limb of the same embryo, the pattern of ex-
pression was radically different from that observed in the so-
mites. Fig. 10 (C and D) shows a group of myogenin+/
MHC- myoblasts, located in the intermediate region of the
limb bud; the figure also shows a single MHC+ myocyte
which does not express detectable levels of myogenin in the
nucleus. During further embryonic development, virtually
all of the newly formed primary fibers, present in both the
body wall and in the limbs of a 13-d.p.c. mouse embryo co-
express MyoD and myogenin in their nucleus, but the inten-
sity of labeling is usually decreased (data not shown).
The data reported above are in apparent contrast with the
results of in situ hybridization where the presence ofmyoge-
nin transcripts in somites of 8.5-d .p.c. mouse embryos was
demonstrated (Sassoon et al., 1989) while MyoD transcripts
1247Figure4 . Double immunofluo-
rescence of embryonic myo-
blasts cultured from 11-d.p.c.
mouseembryo limb buds . Af-
ter3d in culture, the cells were
double stained either with
MF20 mcab (A) and anti-
MyoD pcab (B) or with anti-
MHCpcab (C)andF5Dmcab
(D) . Arrows show MHC+/
myogenin- andMHC-/myo-
genin+ cells . Bar, 15 um .
Figure S. Double immunoflu-
orescence of myoblasts cul-
tured from 8.5-d.p .c . mouse
somites. The cultures were
stained with anti-MHC pcab
(A and C) and F5D mcab (B
and D) at day 1 (A and B)
and day 3 (C and D) in vitro .
Arrows show MHC-/myo-















Figure 6. Time course of appearance of cells positive for MyoD
(-A ), myogenin (. . . si . . .), or MHC (---0---) during culture of
somitic cells. Numbers refer to positive cells/microscopic field.
4 x 10° cells were plated in 100 u1 of complete medium as a
microspot in the center of 30-mm dishes, fixed at daily intervals,
and stained with the different antibodies. In these cultures, <10%
of total cells express any myogenic marker.
could not be detected until 10.5 d .p.c. Although a perfect
temporal correspondence exists between the appearance of
the MyoD transcript at 10.5 d.p.c. and of the corresponding
protein, the appearance of the myogenin transcript appar-
ently precedes the appearance of the corresponding protein
by about two days. To verify that this might not depend upon
trivial reasons, such as different strains of mice or different
staging of the embryos, we prepared serial parasagittal
cryostat sections of 10.5-d.p.c. embryos: one section was in-
cubated with anti-myogenin and anti-MHC antibodies, the
next was hybridized with the same riboprobe specific for the
myogenin transcript described before (Sassoon et al., 1989).
Fig. 11 shows the abundance of myogenin transcripts (Fig.
11 B) and the absence of the corresponding protein (Fig. 11
C) in myotomes which already express MHC (Fig. 11 D).
To rule out that the mcab used (F5D) reacts with an epi-
tope which might be masked (e.g., phosphorylated, methyl-
ated, etc.) at this developmental stage, we repeated the ex-
periments using a variety of anti-myogenin mcabs directed
against epitopes located within different domains of the pro-
tein. In all cases, the results obtained were identical to those
obtained with ID5F7 (data not shown).
BiochemicalAnalysis oftheMyogenin Ranscript
andProtein
To attempt a biochemical comparison between message and
protein, we isolated somites (still connected to neural tubes)
from 193 9.5-d.p.c. mouse embryos (selected at a stage be-
tween 15 and 35 somites), divided these somites into two
randomly selected groups and extracted RNA and high salt
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soluble proteins from them. Fig. 12 A shows a Northern blot
analysis of total RNA isolated from these somites (lane a)
and of the corresponding somites of 11-d.p.c. embryos (lane
b) ; fig. 12 B shows a Western blot analysis of proteins ex-
tracted from the same tissues (somites from 9.5 and 11
d.p.c. ; d and e, respectively). It is clear from the figure that
comparable amounts of myogenin message are present at
both 9.5 and 11 d.p.c., while the myogenin polypeptide can
only be detected at 11 d.p.c. Preliminary experiments using
recombinant myogenin (Wright et al., 1991) had shown that
the sensitivity of the method used would reveal -1-2 ng of
protein (data not shown) . Therefore, assuming that the anti-
body would recognize with similar affinity both recombinant
and natural myogenin, we can tentatively conclude that in 50
ug of our somite extracts (which correspond to -100 hg of
total homogenate), there is <1-2 rig of myogenin (<0.002%
oftotalproteins) at 9.5 d.p.c. and -10 ng ofmyogenin (0.01
of total proteins) at 11 d .p.c.
Discussion
This paper describes the early appearance and spatial distri-
bution ofMyoD and myogenin proteins in the post-implanta-
tion mouse embryo and their expression in myogenic cells
which were cultured from muscles at different stages of de-
velopment. The results show that myoblasts isolated from
limbs at all developmental stages (from 11 d.p.c. to limbs of
adult mice) express MyoD and myogenin in vitro according
to a pattern which has already been described (at the mRNA
level) for many myogenic cell lines (reviewed in Olson,
1990; Weintraub et al., 1991) . MyoD is the first protein to
be expressed in vitro; myogenin rises at the onset of cell
differentiation, immediately followed by the appearance of
myosin and other muscle products. These results suggest that
the phenotypic differences among different myogenic cells
and the fibers they form in vivo or in vitro do not depend on
differential expression of MyoD or myogenin. They might be
related to differential expression of other members of this
gene family such as Myf 5 or MRF4 or to different regula-
tory genes yet to be identified.
A substantial departure from this pattern is found in a
population of myogenic cells, which we term "primordial".
These cells are isolated from newly forming somites and ter-
minally differentiate in vitro without expressing detectable
levels ofMyoD or myogenin proteins in their nuclei. Ifmyo-
genic cellsare isolated from late somites or early limb buds,
a second population appears in vitro which co-express both
MyoD and myogenin in theirnuclei before the onset oftermi-
nal differentiation. These probably represent "embryonic
myoblasts"
The lineage relationship ofprimordial and embryonic my-
ogenic cellsis unclear. Clonal analysis suggests that "primor-
dial"myogenic cellsdivide little or not at all in culture: 80%
ofthe "clones" ofMHC+/myogenin- cellswere single myo-
cites and the five remaining ones were doublets. Further-
more BUdR labeling ofmicromass cultures revealed that all
primordial myocytes were post-mitotic (G. Cossu, unpub-
lished observations). No evidence for a common precursor
was obtained, since no mixed colonies were found and all 17
clones containing three or more nuclei were composed of
MHC+/myogenin+ cells. On the other hand culture condi-
1249Table I . Survival and Differentiation ofMyoblasts
from Somites of9.S-d.p . c . Embryos under Clonal
Culture Conditions
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Cells were cloned by progressive dilution on a STO feeder layer and grown
for 7 d in DME supplemented with 20% FCS and 546 E . E . and then fixed and
double stained with anti-MHC and ID5F7 antibodies as described in Materials
and Methods . No MHC-/myogenin+ cells or mixed clones containing both
myogenin+ and myogenin- cells were detected under these conditions .
Figure 7 . Examples of clones
of somitic myocytes from 9.5-
d.p .c. mouse embryos, double-
stained withF5D mcab (A, C
E, G, I, and K), and anti-
MHC pcab (B, D, F, H, J, and
L) after 7 d in vitro. Note the
absence ofmixed (nryogenin-l
nryogenin+) clones (in E a
spot of fluorescence is seen,
outside the dark shadows of
the nuclei) . Bar, 10 I,m .
tions may simply not have been permissive for the division
of primordial myogenic cells .
During this period of development (from 8 to 11 d.p.c.)
the embryo undergoes a dramatic increase in size, and
moreover, the muscle forming areas increase from a small
portion of the somite to the majority of the available
mesodermal space (Rugh, 1990) . This means that the actual
number of muscle forming cells and already differentiated
muscle undergo an explosive growth during this period and,
if theMyoD-/myogenin- myocytes do not increase innum-
ber (as discussed above), these cells would be lostamong the
multitude of embryonic and fetal myoblasts . Even so, it is
likely that "primordial" precursors migrate to the limb, since
MyoD-/myogenin- differentiated cells can be identified
(although as a very minor fraction) among myogenic cells
cultured from early forming limb buds and also because rare
myogenin-/MHC+ myocytes can be identified in develop-













33 1 1 0
26 1 0 1
8 2 2 0
5 2 0 2
8 3 3 0
6 4 4 0
1 5 5 0
2 8 8 0reveals that both these proteins are present in the forming
myotomes of a 10-d.p.c . mouse embryo : both proteins ap-
pear in an expected cranio-caudal succession, but MHC
expression precedes myogenin expression so that we fre-
quently observed MHC+/myogenin- myotomes but never
a MHC-/myogenin+ myotome . Furthermore, even when
co-expressed in the same myotome, myogenin positive cells
are typically located in the center but not at the edge of the
myotome whereMHC+ (primordial?) myocytes are present .
Even at a later stage ofmyotome maturation, minor lateral
areas of MHC+/myogenin- cells can be observed .
It could be argued that myogenin is not an abundant pro-
tein and therefore its presence at early stages might be unde-
tectable by techniques such as Western blotting orimmuno-
fluorescence, which might nonetheless show the expression
of an abundant protein such asMHC. However, a compari-
son ofthe pattern of expression of these proteins in develop-
ing limb buds argues against such an interpretation : many
myogenin+/MHC- myoblasts can be detected in the limb
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Figure 8 . Double immunofluo-
rescence of a transverse sec-
tion of the trunk of 9.5 d.p .c.
(A and B) and 10.5 d.p .c . (C
and D) and of the limb bud of
11.5-d.p .c . (E and F) mouse
embryos, stained with anti-
MyoD pcab (A, C, and E) and
F5D (B, D, and F) . A and B
were deliberately over exposed
to show absence of nuclear
staining in somites (A and B) .
Note co-staining of virtually
all of the nuclei (C and D) of
the myotomes and of the limb
bud (E and F) . Bar, 50 pm .
buds of the same embryo where myogenin-/MHC+ myo-
tomes were observed . In any case, the level of nuclear ex-
pression which can be revealed by immunofluorescence ob-
viously reflects a considerable accumulation of the protein
within the nucleus so that lower levels of expression might
be functionally importantbut below the threshold of detecta-
bility . This consideration is particularly relevant to the unex-
plained discrepancy between the early detection of the myo-
genin message and the relatively late detection of its protein
product . This is striking when compared to the simultaneous
appearance ofMyoD message and its protein product in the
myotomes as well as to the appearance of both messages
(Sassoon et al., 1989) and related proteins in limb buds . In
the case of myogenin in the somites, the simplest interpreta-
tion of the data is a translation block or decreased half-life
of the protein in 9-d.p.c. embryos. In fact, even considering
the possible increased sensitivity of in situ hybridization over
immunofluorescence, comparison of the relative abundance
of message and protein, by both morphological and bio-
125 1Figure 9 . Double immunofluores-
cence of parasagittal (A-D) or trans-
verse (E and F) sections of 10.5-
d.p.c. mouse embryo, stained with
anti-MHC pcab (A, C, and E), and
F5D (anti-nryogenin) mcab (B, D,
and F) . Arrows show myogenin-
cells at the edge of the myotome
whose center contain myogenin+
cells . Bar, 30 gym .
Figure 10 . Double immunoflu-
orescence of transverse sec-
tions of 11.5-d.p.c. mouseem-
bryo, stained with and-MHC
pcab (A and C) andF5D (anti-
nryogenin) mcab (B and D) .
Arrows show myogenin-/
MHC+ cells in the myotome
(A and B) and a single myo-
genin-/mHC+ myocyte inthe
proximal region of the limb
bud (C and D) . Bar, 20 pm .Figure 11. In situ and double immunofluorescence on serial para-
sagittal sections of 10.5-d.p.c. mouse embryos . One section (phase
contrast in A) was hybridized to myogenin probe (dark field in B) .
The next section was double-stained with F5D (C) and with anti-
MHC pcab (D) . Bar, 20 gm .
chemical methods, clearly shows that a similar amount of
message is accompanied by a striking increase in myogenin
protein between day 9 and 11 ofmouse embryonic develop-
ment . A translational block has been postulated for other
transcription factors such as Growth Hormone Factor 1
whose message is detected at the earliest stages of pituitary
formation, while the corresponding protein can only be de-
tected two days later, when the adenohypophysis has com-
pleted differentiation (Dolly et al ., 1990) . Furthermore,
messages for two contractile proteins, namely the neonatal
myosin heavy chains (Lyons et al ., 1990) and the cardiac
Cusella-De Angelis et al . Primordial Myoblasts in Mouse Somites
troponin I (Ausoni et al ., 1991), are expressed early in rodent
development while the corresponding proteins can be de-
tected only several days later. In all these cases, information
on the molecular basis of this phenomenon has been difficult
to obtain, since little material is available for biochemical
analysis . Control of polyadenylation, such as was found for
maternal messages (Paris and Richter, 1990), does not seem
to be involved (Boucha, M ., and G. Cossu, unpublished
observations) .
In the case of myogenin, a sucrose gradient analysis re-
vealed that the myogenin message is already associated with
the polysome fraction at 9.5 d.p.c . (Boucha, M ., unpub-
lished observations), thus suggesting that the protein may be
translated, but does not accumulate to a level detectable by
antibodies . Since many posttranslational modifications are
required to transport proteins to the nucleus (Silver, 1991),
inefficiency of one of these enzymatic processes might pre-
vent nuclear accumulation of myogenin and eventually in-
crease its rate of cytoplasmic degradation . Whatever the
mechanism underlying the posttranscriptional control of
myogenin accumulation in "primordial myogenic cells, low
levels of myogenin protein do not prevent terminal differenti-
ation of these cells, either in vivo or in vitro. Therefore
"primordial myogenic cells differentiation is either depen-
dent upon very low levels of myogenin or upon the expres-
sion of other, as yet unidentified, regulatory gene products
(see below) .
To understand the possible developmental significance of
these primordial myogenic cells in muscle histogenesis, it is
necessary to obtain a detailed knowledge oftheir appearance
and distribution in vivo . This is not an easy task, especially
because these cells have been characterized by the absence
rather than the presence of an early marker, and therefore
can be identified only by the relatively late appearance of
MHC in their cytoplasm . Recent data on myf-5 transcript ex-
pression in mouse embryogenesis (Ott et al ., 1991), suggest
that this gene product, being the first to be detected in early
forming somites, might selectively regulate differentiation of
these primordial myogenic cells . Unfortunately, to date,
mAbs produced against human recombinant myf-5 have
failed to react with the homologous rodent protein and there-
forewe have not been able to extend this immunohistochemi-
cal analysis to this gene product . Myf-6 transcripts are also
present in early myotomes (Bober et al ., 1991 ; Hinterberger
et al . 1991), although antibodies are not yet available. These
two myogenic factors may substitute for myogenin and
MyoD atthis stage . The initial observations on transcript ac-
cumulation were puzzling in that myf-6 appeared transiently
in early myotomes but was not detectable in the pre-muscle
masses of the limb. In the limb, myf-5 transcripts are present
but only very briefly prior to the expression of muscle struc-
tural genes . These observations can now be interpreted in
terms of the presence of both MyoD and myogenin proteins
in most cells in the pre-muscle masses of the limb, while the
absence of both MyoD and myogenin proteins in the early
somite, may explainwhy both myf-5 and myf-6 are expressed
abundantly there . This would be in keeping with a scheme
in which at least two myogenic regulatory sequences are re-
quired for triggering . muscle differentiation . In muscle cell
lines myogenin is invariably present (Braun et al ., 1990) ;
perhaps myf-6 substitutes for it in the early somite. However,
it is also possible that none of the known HLH family of
genes might be responsible for the differentiation of these
primordial myogenic cells .
1253lanes c and d, respectively . Molecular weight standards were : ß-galactosidase (116 kD),
ovo-albumin (45 kD), and carbonic anhydrase (29 kD) .
As to their possible developmental role, we can only spec-
ulate that these cells, which terminally differentiate earlier
than primary muscle fibers and appear to be post-mitotic,
may play in mammals a similar function to the role played
by pioneer myoblasts in invertebrates (Jensen, 1990) . In the
grasshopper (Ho et al ., 1983) or in the leech (Jellies and
Kristan, 1988), for example, the first myogenic cells that
form in the embryo are disposed in a metameric pattern and
attach to the overlaying ectoderm to define territories where
successive populations of myoblasts will later migrate . Re-
cently muscle precursors expressing a MyoD analog in a
founder cell-like pattern (Michelson et al., 1990 ; Paterson
et al., 1991), have been identified in Drosophila (Bate,
1990) . By analogy, we like to think that pioneer myoblasts
might be needed in vertebrates as well, to define territories
where later embryonic and fetal myoblasts will migrate. In
the absence of a specific marker, and given the size and com-
plexity of higher vertebrate embryos compared to the very
limited number of these primordial myoblasts, they could
have escaped previous investigations (Jacob et al ., 1979 ;
Krenn et al., 1988) .
Further investigation andnew immunological reagents are
required to define the precise phenotype and developmental
role of these "primordial myoblasts .
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